NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a...
Author - David Miller
Researchers identify genetic 'fingerprint' to predict...
Antibiotic resistance is a global public health crisis responsible for more than a million deaths...
FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra
JERSEY CITY, N.J., Jan. 30, 2025 — Celltrion today announced that the U.S. Food and Drug...
Harnessing generative AI to treat undruggable diseases
Biomedical engineers at Duke University have developed an AI-based platform that designs short...
FDA Approves Journavx (suzetrigine), a First-in-Class Treatment...
BOSTON–(BUSINESS WIRE)–Jan. 30, 2025– Vertex Pharmaceuticals Incorporated...
Albion Rye Associates: Account Director – Corporate PR
Competitive: Albion Rye Associates: Account Director – Corporate PR I’m working with an...
Microbial therapy offers new hope for vitiligo patients
A natural compound derived from gut-friendly bacteria significantly slows the progression of...
FDA Approves Ozempic (semaglutide) as the Only GLP-1 RA to...
PLAINSBORO, N.J., Jan. 28, 2025 /PRNewswire/ — Novo Nordisk today announced that the U.S...
Skin cancer: New treatment option successfully tested
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas...
FDA Approves Leqembi (lecanemab-irmb) IV Maintenance Dosing for...
TOKYO and CAMBRIDGE, Mass., January 27, 2025 – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo...